The impaired JAK1 and JAK2 activity was associated with a loss in the capability of IFN-γ to induce growth arrest and apoptosis and enhance immunogenicity mediated by the lack of APM induction in tumor cells [135]. The gene discussed is JAK1; the disease is neoplasm.